From IP to Business - From Cost to Profit
From IP to Business - From Cost to Profit

From IP to Business - From Cost to Profit

Seminar

Referenten: Dr. Andy Stefan Roth, Dr. Jürgen M. Schneider


Veranstaltungsseite:

Sprache: Deutsch

Aufrufe gesamt: 4, letzte 30 Tage: 2

Kontakt

Veranstalter

FORUM · Institut für Management GmbH

FORUM · Institut für Management GmbH

Telefon: +49-6221-500500

Telefax: +49-6221-500505

forum-institut.de/ms/1/23/0...

Preis: 920,-- € zzgl. gesetzl. Mwst.

Kontaktanfrage

Creating value out of patent assets in the Pharma/Biotech landscape: The course provides an overview of all relevant aspects, cases and developments spanning the bridge between patent law and hands-on deal making. The expert-speakers
will address key issues arising around in patents especially in small and medium-size Pharma/Biotech companies, from the patentability of biotech inventions, deal-making tools relating to patentability of biotech inventions to leveraging patents in the Pharma/Biotech Arena. Special emphasis will be given to practical advice for CEO's and patent practitioners in small and medium-size companies where money is in short supply. During two days you will be brought up on how to prepare the patent portfolio of your company for a fnance round, a future exit and partnering with Big Pharma. The course instructors are leading experts in their field and will present proven and reliable solutions as well as alternative ways.



Themen

- Scouting and Partnering - Views from Industry & SME
- Creating a win-win collaboration with Big Pharma
- Achieving an effective license position
- Personalized medicine

Fachthemen

Dr. Andy Stefan Roth

DE, Düsseldorf

DR. ROTH Patentanwaltskanzlei

Publikationen: 1

Veranstaltungen: 6

Aufrufe seit 07/2011: 406
Aufrufe letzte 30 Tage: 4

Veranstaltungen: 9

Aufrufe seit 09/2009: 347
Aufrufe letzte 30 Tage: 2

Zeitpunkt Veranstaltungsort Beschreibung Kontaktperson  
06.12.2013
Amsterdam
Kontaktanfrage